RJA
OPK icon

Raymond James & Associates’s Opko Health OPK Stock Holding History

Raymond James & Associates’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65,000
Closed -$1K – 3363
2016
Q4 		$1K Hold
65,000
– – ﹤0.01% 3228
2016
Q3 		$10K Hold
65,000
– – ﹤0.01% 3169
2016
Q2 		$39K Sell
65,000
-20,900
-24% -$212K ﹤0.01% 2895
2016
Q1 		$33K Buy
+85,900
New +$785K ﹤0.01% 2822

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's OPK Position: Q3 2024 in Review

Raymond James & Associates increased its Opko Health (OPK) stake by 1% in Q3 2024, buying an estimated $594 and bringing the position to 38,665 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

Raymond James & Associates first reported a position in OPK in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.62M in Q3 2016. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

  • Raymond James & Associates held 38,665 shares of Opko Health worth $57.6K as of Q3 2024.
  • Raymond James & Associates bought 400 Opko Health shares in Q3 2024, an estimated $594.
  • Opko Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3837 holding.
  • Raymond James & Associates first reported a position in Opko Health in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Opko Health position peaked at $4.62M in Q3 2016.
  • 234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.